ArticleHeliyon2024

Safety assessment of dapagliflozin: Real-world adverse event analysis based on the FAERS database from 2012 to 2023.

Zhengxi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.